Jiang Zhong PharmaceuticalLtd Future Growth
Future criteria checks 2/6
Jiang Zhong PharmaceuticalLtd is forecast to grow earnings and revenue by 13.1% and 10.3% per annum respectively. EPS is expected to grow by 12.7% per annum. Return on equity is forecast to be 23.8% in 3 years.
Key information
13.1%
Earnings growth rate
12.7%
EPS growth rate
Pharmaceuticals earnings growth | 18.7% |
Revenue growth rate | 10.3% |
Future return on equity | 23.8% |
Analyst coverage | Low |
Last updated | 14 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 5,171 | 996 | N/A | 1,216 | 4 |
12/31/2025 | 4,643 | 882 | N/A | 1,046 | 4 |
12/31/2024 | 4,203 | 766 | N/A | 481 | 4 |
9/30/2024 | 4,125 | 750 | 701 | 905 | N/A |
6/30/2024 | 4,201 | 747 | 768 | 971 | N/A |
3/31/2024 | 4,273 | 733 | 838 | 1,044 | N/A |
12/31/2023 | 4,390 | 708 | 827 | 1,036 | N/A |
9/30/2023 | 4,248 | 686 | 865 | 1,141 | N/A |
6/30/2023 | 4,346 | 656 | 770 | 1,084 | N/A |
3/31/2023 | 4,299 | 657 | 760 | 1,116 | N/A |
12/31/2022 | 3,885 | 598 | 676 | 1,022 | N/A |
9/30/2022 | 3,811 | 559 | 595 | 910 | N/A |
6/30/2022 | 3,509 | 591 | 829 | 1,101 | N/A |
3/31/2022 | 3,127 | 530 | 608 | 834 | N/A |
12/31/2021 | 2,874 | 506 | 729 | 917 | N/A |
9/30/2021 | 2,644 | 528 | 326 | 500 | N/A |
6/30/2021 | 2,549 | 510 | 206 | 357 | N/A |
3/31/2021 | 2,594 | 502 | 507 | 660 | N/A |
12/31/2020 | 2,441 | 474 | 570 | 753 | N/A |
9/30/2020 | 2,481 | 480 | 597 | 714 | N/A |
6/30/2020 | 2,467 | 482 | 749 | 858 | N/A |
3/31/2020 | 2,437 | 468 | 627 | 714 | N/A |
12/31/2019 | 2,449 | 464 | 565 | 641 | N/A |
9/30/2019 | 2,167 | 498 | 661 | 753 | N/A |
6/30/2019 | 2,001 | 494 | 628 | 739 | N/A |
3/31/2019 | 1,832 | 481 | 354 | 463 | N/A |
12/31/2018 | 1,755 | 470 | 365 | 486 | N/A |
9/30/2018 | 1,731 | 450 | 280 | 402 | N/A |
6/30/2018 | 1,764 | 436 | N/A | 313 | N/A |
3/31/2018 | 1,778 | 425 | N/A | 293 | N/A |
12/31/2017 | 1,747 | 418 | N/A | 173 | N/A |
9/30/2017 | 1,764 | 438 | N/A | 263 | N/A |
6/30/2017 | 1,555 | 386 | N/A | 396 | N/A |
3/31/2017 | 1,497 | 374 | N/A | 568 | N/A |
12/31/2016 | 1,548 | 372 | N/A | 698 | N/A |
9/30/2016 | 1,805 | 401 | N/A | 659 | N/A |
6/30/2016 | 2,150 | 424 | N/A | 619 | N/A |
3/31/2016 | 2,455 | 411 | N/A | 534 | N/A |
12/31/2015 | 2,597 | 367 | N/A | 511 | N/A |
9/30/2015 | 2,664 | 332 | N/A | 510 | N/A |
6/30/2015 | 2,763 | 308 | N/A | 512 | N/A |
3/31/2015 | 2,757 | 275 | N/A | 438 | N/A |
12/31/2014 | 2,834 | 265 | N/A | 357 | N/A |
9/30/2014 | 2,952 | 188 | N/A | 294 | N/A |
6/30/2014 | 2,872 | 154 | N/A | 245 | N/A |
3/31/2014 | 2,829 | 142 | N/A | 77 | N/A |
12/31/2013 | 2,778 | 172 | N/A | 112 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 600750's forecast earnings growth (13.1% per year) is above the savings rate (2.8%).
Earnings vs Market: 600750's earnings (13.1% per year) are forecast to grow slower than the CN market (26.1% per year).
High Growth Earnings: 600750's earnings are forecast to grow, but not significantly.
Revenue vs Market: 600750's revenue (10.3% per year) is forecast to grow slower than the CN market (13.8% per year).
High Growth Revenue: 600750's revenue (10.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 600750's Return on Equity is forecast to be high in 3 years time (23.8%)